Aces Diagnostics

QuietHealth & bio · Med devices

ACES Diagnostics, Inc.

Aces Diagnostics has developed LymeSeek, a multiplexed Luminex-based immunoassay that accurately (greater than 90%) detects Lyme disease in patients, including the first 2 weeks after infection.

acesdiagnostics.com · Paradise Valley, AZ

Source Form DCIK 0002039838as of 2026-11-13

Get alerts for raises like this

Funding event

The round itself, as filed

Inferred stageSeries A

Sold of offered$7.1M of $8.7M

Filed2026-10-27

Days since filing17

Exemption claimed: Rule 506(b)
First-ever Form D: No
Date of first sale: 2026-10-22

Investors

No investors named: Form D does not list them

Officers on the filing

Names and roles as filed; addresses are never stored

Tammy CrawfordExecutive Officer · Director
Kim SablichDirector
Linda GiampaDirector
Todd SnowdenDirector
John McDonoughDirector

Health flags

Three flags, each with the raw inputs behind it · as of 2026-11-13

UndersubscribedNot flagged$7.1M of $8.7M sold0.7 months since first sale

Prior raiseNot flaggedRaised $7.1M against a prior $400K$400K prior raise, filed 2026-06-25

AmendedNot flaggedD/A on 2026-06-25amount offered changed from $3.0M

Open roles

On the employer's own careers page · checked 2026-10-27

Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.

No open roles foundWe read careers pages daily.

All filings

Every filing for this company, newest first, amendments included

2026-10-27$7.1M of $8.7MSeries Ainferredsrc Form D
2026-06-25$400K of $3.0MPre-seedinferredsrc Form D
2026-06-25$3.6M of $3.6MSeedinferredAmendmentsrc Form D

Also raised in Health & bio

Same sector, 28 days to 2026-11-15

All Health & bio rounds

OrcosaSeries A · $6.0M of $11.5M · Ewing, NJQuiet ChronicleBioPre-seed · $250K of $1.0M · Menlo Park, CAQuiet

103 rounds in Health & bio in the 28 days to 2026-11-12, against 122 in the 28 days before.

The week, written up